Delivery Order SPE2DB20D2104-SPE2DB22FT90A
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of RABAVERT Rabies Vaccine with diluents. The $36,858.00 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $20,290.20 for the supply of RABAVERT rabies vaccine with diluents. The award was made by the Defense Logistics Agency (DLA), a defense agency, on August 31, 2022, with a completion date of September 1, 2022. The contract is a firm-fixed price delivery order, without any set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp is a major...
- This federal contract award, valued at $13,126.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of RABAVERT RABIES VACC W-DILUENTS, a pharmaceutical product. The contract is a Delivery Order placed under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for...
- This federal contract award, valued at $6,287.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RABAVERT RABIES VACC W-DILUENTS, a vaccine product, with an ultimate completion date of April 23, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This federal contract award is for the delivery of RABAVERT rabies vaccine with diluents, awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $8,951.97 firm fixed-price delivery order was placed by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of September 29, 2023. The contract has no set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of RABAVERT RABIES VACC W-DILUENTS. The $2,948.64 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) on April 20, 2023, with a completion date of April 21, 2023. The contract is not designated with a set-aside. Amerisourcebergen holds two significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,095.80 firm fixed price delivery order is for RABAVERT rabies vaccine with diluents. The contract has a completion date of July 18, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is the prime contractor, and the contract supports DLA's medical supply chain for military...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a $1,198.20 Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA). The contract is to provide RABAVERT rabies vaccine with diluents. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a wide range of pharmaceutical products and...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order valued at $3,440.67 with a Firm Fixed Price pricing type. It is for the procurement of RABAVERT Rabies Vaccine with Diluents, a critical medical commodity used to prevent rabies. The contract has an ultimate completion date of October 25, 2023 and was awarded on October 24, 2023. It was not set aside for any...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. The contract, valued at $5,335.05, is for the provision of RABAVERT Rabies Vaccine with Diluents. As a prime contractor, Amerisourcebergen Drug Corp delivers a wide range of pharmaceutical products and medical supplies to U.S. government agencies, primarily the Department of Defense, through firm...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB22FT90ADelivery Order
This federal contract award, valued at $1,174.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of RABAVERT RABIES VACC W-DILUENTS. This is a firm fixed-price delivery order with an ultimate completion date of September 14, 2022. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/13/22 |